JAMIE GULDEN: Open Payments
NPI 1477641793 · MANASQUAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 82 payments from 20 companies in 2025. Trend: 2023 $17 · 2024 $756 · 2025 $1,433
Food & beverage: $1,433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $219 |
| AstraZeneca Pharmaceuticals LP | 11 | $192 |
| ABBVIE INC. | 11 | $180 |
| Lilly USA, LLC | 9 | $162 |
| Exact Sciences Corporation | 6 | $116 |
| PFIZER INC. | 4 | $69 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 4 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
Products named: Cologuard Collection Kit, JARDIANCE, FARXIGA, Wegovy, MOUNJARO, UBRELVY, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
